Daewoong Pharmaceutical Co., Ltd (KRX:069620)

Daewoong Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,300,209	1,454,393	1,343,932	1,754,469	1,638,243	1,775,845
Market Cap Growth	8.22%	8.22%	-23.40%	7.09%	-7.75%	25.14%
Enterprise Value	2,000,525	2,099,040	1,735,899	2,148,696	2,022,062	2,205,804
Last Close Price	113000.00	126400.00	116232.55	156907.02	145950.84	162053.57
PE Ratio	52.57	58.80	11.04	41.54	66.85	139.25
Forward PE	10.20	14.39	14.77	22.77	41.35	41.35
PS Ratio	0.91	1.02	0.98	1.37	1.42	1.68
PB Ratio	1.64	1.57	1.47	2.37	2.35	2.55
P/TBV Ratio	2.24	2.24	2.15	3.79	3.83	4.26
P/FCF Ratio	-	50.39	33.11	150.21	23.84
P/OCF Ratio	28.25	28.25	9.88	14.84	40.96	17.59
PEG Ratio	0.76	0.24	0.24	0.24	0.24	0.24
EV/Sales Ratio	1.41	1.48	1.26	1.68	1.75	2.09
EV/EBITDA Ratio	11.69	10.81	10.53	15.86	15.60	38.12
EV/EBIT Ratio	16.39	14.45	14.33	22.43	22.79	129.91
EV/FCF Ratio	-19.30	-	65.09	40.55	185.40	29.61
Debt / Equity Ratio	0.74	0.74	0.52	0.60	0.64	0.64
Debt / EBITDA Ratio	3.52	3.52	2.85	3.30	3.44	7.70
Debt / FCF Ratio	-	-	17.61	8.43	40.87	5.98
Asset Turnover	0.76	0.76	0.83	0.86	0.83	0.81
Inventory Turnover	2.77	2.77	3.06	3.39	3.54	3.47
Quick Ratio	0.52	0.52	0.45	0.68	0.72	0.99
Current Ratio	0.97	0.97	0.83	1.16	1.13	1.62
Return on Equity (ROE)	2.54%	2.54%	14.52%	5.44%	4.32%	3.63%
Return on Assets (ROA)	4.84%	4.84%	4.54%	4.03%	3.99%	0.81%
Return on Capital (ROIC)	6.07%	6.07%	5.89%	5.14%	4.86%	0.98%
Return on Capital Employed (ROCE)	10.80%	10.80%	11.30%	8.80%	9.30%	1.60%
Earnings Yield	1.90%	1.70%	9.06%	2.41%	1.50%	0.72%
FCF Yield	-7.97%	-7.13%	1.98%	3.02%	0.67%	4.20%
Payout Ratio	31.29%	31.30%	5.98%	19.10%	26.35%	48.56%
Buyback Yield / Dilution	-0.71%	-0.71%	-3.21%	-0.59%	-3.21%	-3.31%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.